Frederick Raal to Hep G2 Cells
This is a "connection" page, showing publications Frederick Raal has written about Hep G2 Cells.
Connection Strength
0,133
-
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. J Lipid Res. 2016 06; 57(6):1086-96.
Score: 0,133